
Cancer
- Cancer PHGKB -
What's New
Last Posted: Sep 06, 2019
- Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma

JAMA Oncology, September 5, 2019 - Reproducible Findings in Systematic Reviews and Meta-analyses in Oncology Verify, Then Trust

JM Unger, JAMA Oncology, September 5, 2019 - Assessment of Deep Learning Using Nonimaging Information and Sequential Medical Records to Develop a Prediction Model for Nonmelanoma Skin Cancer.

Wang Hsiao-Han et al. JAMA dermatology 2019 Sep - Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.

Xu Xue et al. JAMA network open 2019 Sep (9) e199292 - Has Genomic Medicine Delivered in Cancer?

DJ Kerr, Medscape, August 2019 - What you need to know about ovarian cancer
CDC, 2019 - Breast Cancer Chemoprevention—Can We Make a Case for Precision Medicine?

M Daly et al, JAMA Oncology, September 3, 2019 - CHIPing away at breast cancer

AS Sperling, JNCI, August 2019 - Medications to Reduce Breast Cancer Risk-Promise and Limitations

LE Pace et al, JAMA, September 3, 2019 - Potential impact of immunotherapy agents on cognitive function in cancer patients

F Joly et al, JNCI, August 2019 - Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

S Ghorashian et al, Nature Medicine, September 2, 2019 - Medication Use to Reduce Risk of Breast Cancer- US Preventive Services Task Force Recommendation Statement

USPSTF Recommendation, JAMA, September 3, 2019 - More Treatment Options Emerging for Some Men with Metastatic Prostate Cancer

NCI, 2019 - Developing a digital intervention for cancer survivors: an evidence-, theory- and person-based approach

K Brabdbury et al, NPJ Digital Medicine, September 2, 2019 - Pathogenic Germline Variants in Patients With Metastatic Breast Cancer.

Stuttgen Kelsey et al. JAMA oncology 2019 Aug
No comments:
Post a Comment